Search

Your search keyword '"Voest, Emile"' showing total 599 results

Search Constraints

Start Over You searched for: Author "Voest, Emile" Remove constraint Author: "Voest, Emile" Language english Remove constraint Language: english
599 results on '"Voest, Emile"'

Search Results

1. Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma

2. Optimized whole-genome sequencing workflow for tumor diagnostics in routine pathology practice

3. Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial

4. Author Correction: Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial

6. Trastuzumab plus pertuzumab for HER2-amplified advanced colorectal cancer: Results from the drug rediscovery protocol (DRUP)

9. A pan-cancer analysis of the microbiome in metastatic cancer

10. Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnostics

11. Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer

12. γδ T cells are effectors of immunotherapy in cancers with HLA class I defects

13. Taxanes trigger cancer cell killing in vivo by inducing non-canonical T cell cytotoxicity

16. Delivering precision oncology to patients with cancer

17. The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology

19. Characterization of discordance between mismatch repair deficiency and microsatellite instability testing may prevent inappropriate treatment with immunotherapy.

20. Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol.

23. Caring for patients with cancer in the COVID-19 era

24. Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers

26. Pan-cancer whole-genome analyses of metastatic solid tumours

28. Author Correction: The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology

30. The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies

36. The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact

37. Phase II study (KAMELEON) of single-agent T-DM1 in patients with HER2-positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinoma

42. Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers

43. Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO)

44. ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016

45. Phase II study (KAMELEON) of single-agent T-DM1 in patients with HER2-positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinoma

46. Precision cancer medicine: Concepts, current practice, and future developments.

48. Author Correction: Caring for patients with cancer in the COVID-19 era

50. Identification of patient-specific CD4+ and CD8+ T cell neoantigens through HLA-unbiased genetic screens.

Catalog

Books, media, physical & digital resources